Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Jefferies
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Price: $9.25 +1.98%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 18
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 18
Join SI Premium – FREE
Jefferies analyst Maury Raycroft lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $33.00 (from $36.00) while maintaining a Buy rating.
You May Also Be Interested In
- Truist Securities Downgrades Procept BioRobotics Corp (PRCT) to Hold
- Baker Hughes (BKR) PT Raised to $77 at TD Cowen
- ICICI Securities Downgrades HCL Technologies (HCLT:IN) to Reduce (4)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
